SUTULA STANLEY J III

CFO SUTULA sells 97,843 CL shares ($9.2M) at $94.27, reducing holdings 63.9% to 55,310 shares

SUTULA STANLEY J III, Chief Financial Officer of Colgate-Palmolive, sold 97,843 shares for $9,223,287.81 at $94.27 per share on 2026-02-04, reducing his stake by 63.9% from 153,153 shares to 55,310 shares. His prior trades at CL show a 100% well-timed rate at the 90-day mark (2 of 2 prior sells preceded stock declines), suggesting pattern recognition in his exits. The current price of $94.41 sits -3.2% from the 52-week high of $97.50, and the stock has appreciated +22.5% over the prior 30 days and +19.9% over 90 days—a context where the executive divested after material gains. The substantial reduction in personal holdings merits tracking against CL's fundamentals (P/E of 26.15, net income of $735,000,000.00 on $5,131,000,000.00 quarterly revenue) and near-peak pricing relative to the annual range.

CFO Stanley Sutula sells 45,410 CL shares at $94.11; reduces stake by 55.3% to 36,726 shares

Stanley Sutula, CFO of Colgate Palmolive, sold 45,410 shares on 2024-11-05 at $94.11, reducing his holdings by 55.3% from 82,136 shares to 36,726 shares. The $4,273,426.12 transaction occurred just four days after a prior sale on 2024-11-01 at the same ticker, suggesting a deliberate multi-step reduction of his equity position. Against current market conditions, the stock trades at $90.77—approximately 3.5% below the transaction price—and is down 16.6% from its 52-week high of $108.77. The timing relative to prior outcomes at this ticker remains unmeasurable (the 2024-11-01 sale is too recent for 90-day assessment), and his broader cross-ticker track record shows only 1 prior sell with no statistically meaningful pattern. The sale represents a material reduction of insider equity exposure in a company trading at a P/E of 25.86.

CFO Sutula sold 50,000 CL shares (57.7% of holdings) at $93.53 on 2024-11-01; stock down 8.0% in 90d.

SUTULA STANLEY J III, Chief Financial Officer, executed an open-market sale of 50,000 shares valued at $4,676,310.00, reducing his holdings from 86,726 shares to 36,726 shares. The sale reduced his position by 57.7%. Since the sale on 2024-11-01 at $93.53, the stock has declined 8.0% over 90 days, falling to the current price of $94.26 which is also 13.3% below the 52-week high. His cross-ticker track record shows only 1 prior sell historically, providing limited precedent for evaluating his selling patterns. The timing of this concentrated reduction in stake during a period of stock weakness may warrant investor attention to whether executive confidence is declining alongside the recent price deterioration, though the limited trading history constrains any firm conclusion.